MiLaboratories develops medical imaging software that utilizes advanced bioinformatics tools to analyze complex immune sequencing data. The platform facilitates experiment planning, sample preparation, and data processing, enabling clinicians and researchers to identify diagnostic patterns in autoimmune diseases.
Funding
$12.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
KFFounders
Product
Problem
Analyzing complex immune sequencing data to identify diagnostic patterns in autoimmune diseases is challenging due to the computational complexity and the need for specialized bioinformatics tools. Traditional methods often require extensive manual processing and lack the scalability needed for large-scale studies.
Solution
MiLaboratories develops a computational biology platform designed to streamline the analysis of immune repertoire sequencing data. The platform offers tools for experiment planning, sample preparation, and automated data processing, enabling researchers and clinicians to identify relevant biomarkers and understand immune responses. By automating and standardizing the analysis pipeline, MiLaboratories facilitates the discovery of diagnostic and prognostic signatures in autoimmune and infectious diseases.
Target Audience
The primary users are researchers and clinicians in immunology, autoimmune disease, and infectious disease who need to analyze immune repertoire sequencing data to identify diagnostic and prognostic biomarkers.
Features
- Automated processing of raw sequencing data, including quality control, read alignment, and error correction
- Advanced algorithms for identifying and quantifying immune cell populations and clonal lineages
- Integrated tools for visualizing and exploring immune repertoire diversity and dynamics
- Support for various sequencing platforms and data formats
- Cloud-based infrastructure for scalable data storage and analysis